Portfolio comparison
University of Pennsylvania Penn vs Gilead Sciences Inc
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania Penn
Patents indexed
4
Year range
2012 – 2024
Most recent
2024
biotechpharmaceuticalgene_editingoncologytelecommunications
Top Patents4 enriched
US 8278036· 2012
How Modified RNA Tricks Cells Into Making Proteins Without Triggering Attacks
US 9481728· 2016
How Genetically Modified T-Cells Fight CD19 Cancers
US 9328156· 2016
How Genetically Modified T-Cells Attack Cancer
Activity by Decade
2010s3
2020s1
Company B
Gilead Sciences Inc
Patents indexed
3
Year range
2013 – 2017
Most recent
2017
biotechpharmaceutical
Top Patents3 enriched
US 8592397· 2013
How Gilead Made a Stable HIV Pill Combining Two Medicines
US 9216996· 2015
Gilead's Chemical Compounds for Treating HIV Infections
US 9744181· 2017
How Gilead Stabilized the HIV Combination Pill Truvada
Activity by Decade
2010s3
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.